View in EDS

Design of a Tumor Binding GMCSF as Intratumoral Immunotherapy of Solid Tumors.

Saved in:
Bibliographic Details
Title: Design of a Tumor Binding GMCSF as Intratumoral Immunotherapy of Solid Tumors.
Authors: Chakravarti AR; Bioengineering Program, The University of Kansas, Lawrence, Kansas 66045, United States., Groer CE; HylaPharm, LLC, Lawrence, Kansas 66047, United States.; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Gong H; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Yudistyra V; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66045, United States., Forrest ML; HylaPharm, LLC, Lawrence, Kansas 66047, United States.; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Berkland CJ; Bioengineering Program, The University of Kansas, Lawrence, Kansas 66045, United States.; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States.; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66045, United States.
Source: Molecular pharmaceutics [Mol Pharm] 2023 Apr 03; Vol. 20 (4), pp. 1975-1989. Date of Electronic Publication: 2023 Feb 24.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36825806
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Design of a Tumor Binding GMCSF as Intratumoral Immunotherapy of Solid Tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chakravarti+AR%22">Chakravarti AR</searchLink>; Bioengineering Program, The University of Kansas, Lawrence, Kansas 66045, United States.<br /><searchLink fieldCode="AU" term="%22Groer+CE%22">Groer CE</searchLink>; HylaPharm, LLC, Lawrence, Kansas 66047, United States.; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States.<br /><searchLink fieldCode="AU" term="%22Gong+H%22">Gong H</searchLink>; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States.<br /><searchLink fieldCode="AU" term="%22Yudistyra+V%22">Yudistyra V</searchLink>; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66045, United States.<br /><searchLink fieldCode="AU" term="%22Forrest+ML%22">Forrest ML</searchLink>; HylaPharm, LLC, Lawrence, Kansas 66047, United States.; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States.<br /><searchLink fieldCode="AU" term="%22Berkland+CJ%22">Berkland CJ</searchLink>; Bioengineering Program, The University of Kansas, Lawrence, Kansas 66045, United States.; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States.; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66045, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101197791%22">Molecular pharmaceutics</searchLink> [Mol Pharm] 2023 Apr 03; Vol. 20 (4), pp. 1975-1989. <i>Date of Electronic Publication: </i>2023 Feb 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101197791 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1543-8392 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215438384%22">15438384 </searchLink><i>NLM ISO Abbreviation: </i>Mol Pharm <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36825806
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1021/acs.molpharmaceut.2c00897
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1975
    Titles:
      – TitleFull: Design of a Tumor Binding GMCSF as Intratumoral Immunotherapy of Solid Tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chakravarti AR
      – PersonEntity:
          Name:
            NameFull: Groer CE
      – PersonEntity:
          Name:
            NameFull: Gong H
      – PersonEntity:
          Name:
            NameFull: Yudistyra V
      – PersonEntity:
          Name:
            NameFull: Forrest ML
      – PersonEntity:
          Name:
            NameFull: Berkland CJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 04
              Text: 2023 Apr 03
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1543-8392
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Molecular pharmaceutics
              Type: main
ResultId 1